Showing results (1-10 of 242) with videos related to
Sort By:
Pageof 25
Oncology (Williston Park, N.Y.)|May 10, 2011
Epigenetics in cancer: what's the future?Yanis Boumber, Jean-Pierre J IssaPlos One|May 1, 2008
Downregulation of histone H3 lysine 9 methyltransferase G9a induces centrosome disruption and chromosome instability in cancer cellsYutaka Kondo, Lanlan Shen, Saira Ahmed, et al.Cancer Research|December 7, 2007
Drug sensitivity prediction by CpG island methylation profile in the NCI-60 cancer cell line panelLanlan Shen, Yutaka Kondo, Saira Ahmed, et al.Current Oncology (Toronto, Ont.)|February 26, 2026
SMARCA4-Deficient Carcinomas of the Small Intestine: A Systematic ReviewAaqid Syed, Yanis Boumber, Midhun MallaFrontiers in Oncology|July 7, 2025
HER2 alterations in non-small cell lung cancer (NSCLC): from biology and testing to advances in treatment modalitiesAhmed Ismail, Aakash Desai, Yanis BoumberCureus|December 25, 2025
Sarcoidosis With Isolated Osseous Manifestations Mimicking Metastatic MalignancyAhmed Ismail, Ahmed Saleh, Yanis BoumberCancer|November 7, 2019
Biomarkers for immune checkpoint inhibition in non-small cell lung cancer (NSCLC)J Nicholas Bodor, Yanis Boumber, Hossein BorghaeiExpert Opinion on Investigational Drugs|May 11, 2011
Mocetinostat (MGCD0103): a review of an isotype-specific histone deacetylase inhibitorYanis Boumber, Anas Younes, Guillermo Garcia-ManeroClinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 17, 2007
DNA methylation as a therapeutic target in cancerJean-Pierre J IssaBlood|May 11, 2013
The myelodysplastic syndrome as a prototypical epigenetic diseaseJean-Pierre J IssaPageof 25